PET tracers are aimed to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks of Alzheimer’s disease. Initially Lilly will integrate the new technology
The company is planning to equip its national sales force with StayinFront TouchRx on iPads and management team with StayinFront EdgeRx . SaaS-based StayinFront’s EdgeRx and TouchRx provide
Cetrotide is used in women undergoing infertility treatment for the regulation of hormone responses. Presently, Merck Serono is marketing the product across the world except Japan. The transaction,
As part of the synergy, the companies will launch hybrid business model. Ranbaxy will support Daiichi Sankyo Brasil Farmaceutica, Daiichi Sankyo’s Brazilian subsidiary, to enter into branded generics
Investigational drug Ruconest 50 U/kg is being developed for the treatment of acute angioedema attacks in patients with hereditary angioedema (HAE). A Phase III randomized placebo-controlled study conducted
In pre-clinical asthma models ASM-024 exhibited the capabilities of inhibitory effects on inflammation, bronchoprotection and smooth muscle relaxation. Asmacure founder and chief medical officer Yvon Cormier said the
The site, which is part of the Group’s Specialist Packaging Division, has invested in the Prati Vega booklet-label machine to further improve its quality performance across several study
The BCID panel provides automatic results for the most common infectious causes of sepsis and simultaneously tests positive blood cultures for approximately 90% of the gram-positive bacteria, gram-negative
Mochida Pharmaceutical obtained drug marketing approval for Epadel T, indicated for triglyceride levels that are in the borderline region. The ethical drugs Epadel were converted into an OTC
The primary efficacy endpoints of both the AWARD-2 and AWARD-4 studies were non-inferiority to insulin glargine, as measured by the reduction of hemoglobin A1c (HbA1c) levels at the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.